Chinese expert consensus on the application of immune checkpoint inhibitors in liver transplantation for hepatocellular carcinoma

被引：0
|
作者：
Wang, Zhengxin [1 ]
Yang, Jiayin [2 ]
Li, Guangming [3 ]
机构：
[1] Fudan Univ, Huashan Hosp, Organ Transplantat Inst, Liver Transplantat Ctr,Gen Surg Dept, Shanghai 200040, Peoples R China
[2] Sichuan Univ, West China Hosp, Organ Transplantat Ctr, Chengdu 610044, Sichuan, Peoples R China
[3] Capital Med Univ, Beijing Youan Hosp, Liver Transplantat Ctr, Gen Surg Dept, Beijing 100069, Peoples R China
来源：
CHINESE MEDICAL JOURNAL | 2024年 / 137卷 / 18期
基金：
北京市自然科学基金; 中国国家自然科学基金;
关键词：
D O I：
10.1097/CM9.0000000000003237
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2143 / 2145
页数：3
相关论文
共 50 条
  • [1] Chinese expert consensus on the application of immune checkpoint inhibitors in liver transplantation for hepatocellular carcinoma
    Wang Zhengxin
    Yang Jiayin
    Li Guangming
    中华医学杂志英文版, 2024, 137 (18)
  • [2] Liver Transplantation for Hepatocellular Carcinoma in the Era of Immune Checkpoint Inhibitors
    De Stefano, Nicola
    Patrono, Damiano
    Colli, Fabio
    Rizza, Giorgia
    Paraluppi, Gianluca
    Romagnoli, Renato
    CANCERS, 2024, 16 (13)
  • [3] Bibliometric analysis of immune checkpoint inhibitors to treat hepatocellular carcinoma in patients with liver transplantation
    Ou, Yanjiao
    Liao, Rui
    ASIAN JOURNAL OF SURGERY, 2025, 48 (01) : 708 - 709
  • [4] Liver Transplantation for Hepatocellular Carcinoma after Downstaging or Bridging Therapy with Immune Checkpoint Inhibitors
    Gao, Qimeng
    Anwar, Imran J.
    Abraham, Nader
    Barbas, Andrew S.
    CANCERS, 2021, 13 (24)
  • [5] Immune Checkpoint Inhibitors as Therapy to Down-Stage Hepatocellular Carcinoma Prior to Liver Transplantation
    Katariya, Nitin N.
    Lizaola-Mayo, Blanca C.
    Chascsa, David M.
    Giorgakis, Emmanouil
    Aqel, Bashar A.
    Moss, Adyr A.
    Uson Junior, Pedro Luiz Serrano
    Borad, Mitesh J.
    Mathur, Amit K.
    CANCERS, 2022, 14 (09)
  • [6] Immune checkpoint inhibitors for hepatocellular carcinoma
    El Dika, Imane
    Khalil, Danny N.
    Abou-Alfa, Ghassan K.
    CANCER, 2019, 125 (19) : 3312 - 3319
  • [7] Immune checkpoint inhibitors for hepatocellular carcinoma
    Jensen, Christopher E.
    Loaiza-Bonilla, Arturo
    Bonilla-Reyes, Paula A.
    HEPATIC ONCOLOGY, 2016, 3 (03) : 201 - 211
  • [8] Chinese Multidisciplinary Expert Consensus on Immune Checkpoint Inhibitor-Based Combination Therapy for Hepatocellular Carcinoma (2023 Edition)
    Liu, Xiufeng
    Lu, Yinying
    Zhou, Weiping
    Peng, Tao
    Zhou, Jie
    Bi, Huaqiang
    Xia, Feng
    Chen, Xiaoping
    LIVER CANCER, 2024, 13 (04) : 355 - 375
  • [9] Liver injury by immune checkpoint inhibitors in patients with hepatocellular carcinoma.
    Personeni, Nicola
    Pressiani, Tiziana
    Capogreco, Antonio
    Dal Buono, Arianna
    D'Alessio, Antonio
    Prete, Maria Giuseppina
    Smiroldo, Valeria
    Bozzarelli, Silvia
    Giordano, Laura
    Aghemo, Alessio
    Santoro, Armando
    Rimassa, Lorenza
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [10] Immune checkpoint inhibitor for hepatocellular carcinoma recurrence after liver transplantation
    Li Zhuang
    Hai-Bo Mou
    Lan-Fang Yu
    Heng-Kai Zhu
    Zhe Yang
    Qin Liao
    Shu-Sen Zheng
    Hepatobiliary&PancreaticDiseasesInternational, 2020, 19 (01) : 91 - 93
12345